Surface Oncology CEO Robert Ross' 2021 pay jumps 318% to $4.7M
Surface Oncology reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Surface Oncology reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, four executives at Surface Oncology received on average a compensation package of $2M, a 49% increase compared to previous year.
Average pay of disclosed executives at Surface Oncology
Robert W. Ross, Chief Executive Officer, received $4.7M in total, which increased by 318% compared to 2020. 83% of Ross' compensation, or $3.9M, was in option awards. Ross also received $294K in non-equity incentive plan, $506K in salary, as well as $13K in other compensation.
Alison O'Neill, Chief Medical Officer, received a compensation package of $1.2M, which increased by 43% compared to previous year. 47% of the compensation package, or $586K, was in option awards.
Vito J. Palombella, Chief Scientific Officer, earned $1.2M in 2021, a 7% increase compared to previous year.
J. Jeffrey Goater, Chief Executive Officer, received $933K in 2021, which decreases by 60% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 26, 2022.